Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yun, Chul Won | - |
dc.contributor.author | Kim, Hyung Joo | - |
dc.contributor.author | Lim, Ji Ho | - |
dc.contributor.author | Lee, Sang Hun | - |
dc.date.accessioned | 2021-08-11T08:39:01Z | - |
dc.date.available | 2021-08-11T08:39:01Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 2073-4409 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/3235 | - |
dc.description.abstract | Heat shock proteins (HSPs) constitute a large family of molecular chaperones classified by their molecular weights, and they include HSP27, HSP40, HSP60, HSP70, and HSP90. HSPs function in diverse physiological and protective processes to assist in maintaining cellular homeostasis. In particular, HSPs participate in protein folding and maturation processes under diverse stressors such as heat shock, hypoxia, and degradation. Notably, HSPs also play essential roles across cancers as they are implicated in a variety of cancer-related activities such as cell proliferation, metastasis, and anti-cancer drug resistance. In this review, we comprehensively discuss the functions of HSPs in association with cancer initiation, progression, and metastasis and anti-cancer therapy resistance. Moreover, the potential utilization of HSPs to enhance the effects of chemo-, radio-, and immunotherapy is explored. Taken together, HSPs have multiple clinical usages as biomarkers for cancer diagnosis and prognosis as well as the potential therapeutic targets for anti-cancer treatment. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/cells9010060 | - |
dc.identifier.scopusid | 2-s2.0-85085764661 | - |
dc.identifier.wosid | 000515398200060 | - |
dc.identifier.bibliographicCitation | Cells, v.9, no.1 | - |
dc.citation.title | Cells | - |
dc.citation.volume | 9 | - |
dc.citation.number | 1 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | SQUAMOUS-CELL CARCINOMA | - |
dc.subject.keywordPlus | 1,3,5-TRIHYDROXY-13,13-DIMETHYL-2H-PYRAN 7,6-B XANTHONE | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR HSF1 | - |
dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
dc.subject.keywordPlus | HSP90 INHIBITOR | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | PANCREATIC-CANCER | - |
dc.subject.keywordPlus | DRUG-RESISTANCE | - |
dc.subject.keywordPlus | MORTALIN CONTRIBUTES | - |
dc.subject.keywordAuthor | heat shock proteins | - |
dc.subject.keywordAuthor | cancer therapy | - |
dc.subject.keywordAuthor | chemoresistance | - |
dc.subject.keywordAuthor | radiotherapy | - |
dc.subject.keywordAuthor | immunotherapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.